Identification | Back Directory | [Name]
Ethyl5-bromo-1,3,4-thiadiazole-2-carboxylate | [CAS]
1030613-07-0 | [Synonyms]
149131 Ethyl5-bromo-1,3,4-thiadiazole-2-carboxylate Ethyl 5-bromo-1,3,4-thiadiazole-2-carboxylate 97+% 5-Bromo-[1,3,4]thiadiazole-2-carboxylic acid ethyl ester 1,3,4-Thiadiazole-2-carboxylic acid, 5-bromo-, ethyl ester | [Molecular Formula]
C5H5BrN2O2S | [MDL Number]
MFCD12165919 | [MOL File]
1030613-07-0.mol | [Molecular Weight]
237.07 |
Chemical Properties | Back Directory | [Boiling point ]
305.6±25.0 °C(Predicted) | [density ]
1.743±0.06 g/cm3(Predicted) | [storage temp. ]
under inert gas (nitrogen or Argon) at 2–8 °C | [pka]
-4.01±0.10(Predicted) | [Appearance]
Off-white to light yellow Solid | [InChI]
InChI=1S/C5H5BrN2O2S/c1-2-10-4(9)3-7-8-5(6)11-3/h2H2,1H3 | [InChIKey]
KDZLTNORBKZJKE-UHFFFAOYSA-N | [SMILES]
S1C(Br)=NN=C1C(OCC)=O |
Hazard Information | Back Directory | [Uses]
Ethyl 5-?Bromo-?1,?3,?4-?thiadiazole-?2-?carboxylate can be used as reactant/reagent in preparation of hydroxyalkyl thiadiazole derivatives as antibacterials. | [Synthesis]
Ethyl 2-amino-1,3,4-thiadiazole-5-carboxylate (21 g, 121.38 mmol) was used as starting material, which was dissolved in acetonitrile (400 mL), copper (II) bromide (53.3 g, 239.01 mmol) was added with stirring, and stirred at room temperature for 15 min. Subsequently, tert-butyl nitrite (24.65 g, 239.04 mmol) was slowly added dropwise over 20 minutes. After the dropwise addition, the reaction mixture was continued to be stirred at room temperature for 30 min and then warmed up to 60 °C for 30 min. The reaction process was monitored by thin layer chromatography (TLC). Upon completion of the reaction, the mixture was diluted with water, extracted with ethyl acetate and filtered through a bed of diatomaceous earth. The organic layer was separated, washed with saturated brine, dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure to afford the target product ethyl 5-bromo-1,3,4-thiadiazole-2-carboxylate (25 g, 87.40% yield) as a yellow solid.TLC conditions: 20% ethyl acetate/hexane (Rf value: 0.7).1H NMR (400 MHz, DMSO-d6) data: δ 4.45-4.40 (m, 2H), 1.34 (t, J=6.8Hz, 3H). | [References]
[1] Journal of Medicinal Chemistry, 2011, vol. 54, # 14, p. 5082 - 5096 [2] Patent: WO2018/160878, 2018, A1. Location in patent: Page/Page column 219 [3] Patent: WO2011/146817, 2011, A1. Location in patent: Page/Page column 57-58 [4] Patent: WO2013/110643, 2013, A1. Location in patent: Paragraph 00332; 00333 [5] Patent: WO2013/49565, 2013, A1. Location in patent: Page/Page column 69 |
|
|